key considerations when treating patients with cll who have pre-existing cardiovascular disease
Published 1 day ago • 5 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
1:45
managing cardiovascular risks in patients with chip and mpns: insights from a cardiologist
-
1:04
clinical approaches to fertility and pregnancy in patients with mpns
-
4:11
a study of alloimmunization in pregnant patients with scd receiving chronic vs on-demand transfusion
-
4:47
practical advice for the management of patients with cml who are pregnant or wish to conceive
-
4:38
patient selection for investigating the use of heparin as thromboprophylaxis in pregnancy
-
1:50
criteria for the diagnosis of accelerated/blast phase mpn and challenges clinicians may face
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
2:45
continuity of care for patients with hematological predispositions to aml
-
2:57
risk factors for venous thromboembolic events in pregnant patients with scd
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
0:58
reducing inequalities in the diagnosis and treatment of hematological malignancies
-
0:43
the development of a composite comorbidity index to predict car-t outcomes in patients with dlbcl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:07
the clearance of driver mutations following allosct impacts myelofibrosis disease outcomes
-
2:33
the effect of lymphodepleting agents on rate and severity of toxicities following car-t infusion
-
7:30
updates from juliet: correlative analyses and clinical characteristics associated with efficacy
-
3:34
planned preventive maintenance of ultrasound
-
3:40
outcomes of all stratified by socioeconomic factors